After her cancer diagnosis, Noel Sumner was offered an experimental high-dose chemotherapy trial.
“My participation in this trial was only made possible (and tolerable) by Professor Don Metcalf at WEHI,” she says.
Professor Metcalf and his colleagues had discovered and developed colony stimulating factors (CSFs) – drugs that help to boost the infection-fighting white blood cells in people undergoing cancer treatment.
Since these early stages, an estimated 20 million people have been treated with CSFs.